![HCA Healthcare, Inc. Website](https://cdn.finchat.io/261825.png)
HCA Healthcare, Inc.
NYSE-HCA
Company Overview
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Name
HCA Healthcare, Inc.
CEO
Mr. Samuel N. Hazen
Website
www.hcahealthcare.com
Sector
Health Care Providers and Services
Year Founded
1968
Profile
Market Cap
$102.65B
EV
$147.44B
Shares Out
258.07M
Revenue
$68.35B
Employees
265,000
Margins
Gross
40.27%
EBITDA
19.54%
Operating
14.9%
Pre-Tax
12.38%
Net
8.4%
FCF
7.15%
Returns (5Yr Avg)
ROA
10.22%
ROTA
257.33%
ROE
20.15%
ROCE
21.86%
ROIC
17.13%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$396.6
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$918M
Net Debt
$41.86B
Debt/Equity
31.94
EBIT/Interest
5.11
Growth (CAGR)
Rev 3Yr
6.86%
Rev 5Yr
6.95%
Rev 10Yr
6.81%
Dil EPS 3Yr
13.48%
Dil EPS 5Yr
15.45%
Dil EPS 10Yr
19.69%
Rev Fwd 2Yr
7.21%
EBITDA Fwd 2Yr
7.63%
EPS Fwd 2Yr
14.1%
EPS LT Growth Est
12.51%
Dividends
Yield
—
Payout
11.68%
DPS
$2.52
DPS Growth 3Yr
37.95%
DPS Growth 5Yr
10.93%
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
5.65%